BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 15034750)

  • 1. Evaluation of classification criteria for juvenile-onset spondyloarthropathies.
    Kasapçopur O; Demirli N; Ozdoğan H; Apelyan M; Calişkan S; Sever L; Arisoy N
    Rheumatol Int; 2005 Aug; 25(6):414-8. PubMed ID: 15034750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The performance of classification criteria for juvenile spondyloarthropathies.
    Adrovic A; Sezen M; Barut K; Sahin S; Acikel C; Demirkaya E; Kasapcopur O
    Rheumatol Int; 2017 Dec; 37(12):2013-2018. PubMed ID: 29018906
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of ILAR classification criteria for juvenile idiopathic arthritis in Spanish children.
    Merino R; De Inocencio J; García-Consuegra J
    J Rheumatol; 2001 Dec; 28(12):2731-6. PubMed ID: 11764225
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sensitivity and specificity of criteria for spondyloarthritis in children with late onset pauciarticular juvenile chronic arthritis as well as their characteristics.
    Joos R; Dehoorne J; Hoffman I; Mielants H; Verbruggen G; Elewaut D
    Clin Exp Rheumatol; 2009; 27(5):870-6. PubMed ID: 19917176
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The frequency of juvenile spondyloarthropathies in childhood familial Mediterranean fever.
    Ozer E; Seker D; Taner E; Adrovic A; Sahin S; Barut K; Kasapçopur O
    Clin Exp Rheumatol; 2018; 36(6 Suppl 115):141-145. PubMed ID: 30418123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biologic agents in juvenile spondyloarthropathies.
    Katsicas MM; Russo R
    Pediatr Rheumatol Online J; 2016 Mar; 14(1):17. PubMed ID: 26968522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retrospective study of juvenile spondylarthropathies in Croatia over the last 11 years.
    Prutki M; Tambic Bukovac L; Jelusic M; Potocki K; Kralik M; Malcic I
    Clin Exp Rheumatol; 2008; 26(4):693-9. PubMed ID: 18799108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Juvenile spondyloartropathies.
    Yıldız M; Haşlak F; Adroviç A; Şahin S; Barut K; Kasapçopur Ö
    Eur J Rheumatol; 2022 Jan; 9(1):42-49. PubMed ID: 34101576
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The potential of ESSG spondyloarthropathy classification criteria as a diagnostic aid in rheumatological practice.
    Gomariz EM; del M; Guijo VP; Contreras AE; Villanueva M; Estévez EC
    J Rheumatol; 2002 Feb; 29(2):326-30. PubMed ID: 11838851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Juvenile Spondyloarthropathies.
    Adrovic A; Barut K; Sahin S; Kasapcopur O
    Curr Rheumatol Rep; 2016 Aug; 18(8):55. PubMed ID: 27402112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spondylarthropathies in children--are they different from those in adults?
    Hofer M
    Best Pract Res Clin Rheumatol; 2006 Apr; 20(2):315-28. PubMed ID: 16546059
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tarsitis as an initial manifestation of juvenile spondyloarthropathy.
    Alvarez-Madrid C; Merino R; De Inocencio J; García-Consuegra J
    Clin Exp Rheumatol; 2009; 27(4):691-4. PubMed ID: 19772808
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The prevalence of spondyloarthropathy in fibromyalgia patients.
    Kaşkari D; Yücel AE; Ağildere M
    Mod Rheumatol; 2017 Sep; 27(5):875-880. PubMed ID: 27919196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacotherapy for juvenile spondyloarthritis: an overview of the available therapies.
    Marino A; De Souza M; Giani T; Cimaz R
    Expert Opin Pharmacother; 2020 Dec; 21(17):2161-2168. PubMed ID: 32726179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A short-term follow-up of enthesitis and arthritis in the active phase of juvenile onset spondyloarthropathies.
    Burgos-Vargas R; Pacheco-Tena C; Vázquez-Mellado J
    Clin Exp Rheumatol; 2002; 20(5):727-31. PubMed ID: 12412210
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of the European Spondyloarthropathy Study Group (ESSG) classification criteria in a Chinese population.
    Zhao L; Liao Z; Yu D; Li T; Gu J
    Clin Exp Rheumatol; 2005; 23(3):397-9. PubMed ID: 15971431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Classification of the spondyloarthropathies.
    Healy PJ; Helliwell PS
    Curr Opin Rheumatol; 2005 Jul; 17(4):395-9. PubMed ID: 15956834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HLA-B*27/HLA-B*07 in combination with D6S273-134 allele is associated with increased susceptibility to juvenile spondyloarthropathies.
    Harjacek M; Margetić T; Kerhin-Brkljacić V; Martinez N; Grubić Z
    Clin Exp Rheumatol; 2008; 26(3):498-504. PubMed ID: 18578977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The place of juvenile onset spondyloarthropathies in the Durban 1997 ILAR classification criteria of juvenile idiopathic arthritis. International League of Associations for Rheumatology.
    Burgos-Vargas R; Rudwaleit M; Sieper J
    J Rheumatol; 2002 May; 29(5):869-74. PubMed ID: 12022342
    [No Abstract]   [Full Text] [Related]  

  • 20. Validation of the proposed ILAR classification criteria for juvenile idiopathic arthritis. International League of Associations for Rheumatology.
    Foeldvari I; Bidde M
    J Rheumatol; 2000 Apr; 27(4):1069-72. PubMed ID: 10782839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.